Polyphor have successfully completed a Phase I trial of CXCR4 inhibitor POL6326 for use in hematopoietic stem cell (HSC) transplantation and leukemia.… more →
GPCR Newspatoconnor wrote 3 months ago: Role of lymphangiogenesis in cancer. BIOLOGY OF NEOPLASIA J Clin Oncol. 2007 Sep Sundar SS, Ganesan … more →
liechti wrote 10 months ago: HIV could infect a human in two different ways. Trans-infection means the infection of CD4+ T cells … more →
crimsoncanary wrote 1 year ago: Polyphor have successfully completed a Phase I trial of CXCR4 inhibitor POL6326 for use in hematopoi … more →
crimsoncanary wrote 1 year ago: Chemokine Therapeutics SDF-1 agonist CTCE-9908 has shown efficacy in a Phase I/II trial in patients … more →
mlinde wrote 1 year ago: I read in the Wall Street Journal today that Pfizer is going to try and reformulate maraviroc (Selze … more →